Identification of putative biomarkers for prediabetes by metabolome analysis of rat models of type 2 diabetes
Tóm tắt
Biomarkers for the development of type 2 diabetes (T2D) are useful for prediction and intervention of the disease at earlier stages. In this study, we performed a longitudinal study of changes in metabolites using an animal model of T2D, the spontaneously diabetic Torii (SDT) rat. Fasting plasma samples of SDT and control Sprague-Dawley (SD) rats were collected from 6 to 24 weeks of age, and subjected to gas chromatography–mass spectrometry-based metabolome analysis. Fifty-nine hydrophilic metabolites were detected in plasma samples, including amino acids, carbohydrates, sugars and organic acids. At 12 weeks of age, just before the onset of diabetes in SDT rats, the amounts of nine of these metabolites (asparagine, glutamine, glycerol, kynurenine, mannose, n-alpha-acetyllysine, taurine, threonine, and tryptophan) in SDT rats were significantly different from those in SD rats. In particular, metabolites in the tryptophan metabolism pathway (tryptophan and kynurenine) were decreased in SDT rats at 12 weeks of age and later. The lower tryptophan and kynurenine levels in the prediabetic state and later were further confirmed by a replication study on SDT rats and by a longitudinal study on another animal model of T2D, the Otsuka Long-Evans Tokushima Fatty rat. Our data indicate that tryptophan and its metabolites are potential biomarkers for prediabetes and that tryptophan metabolism may be a potential target of intervention for treatment of the disease.
Tài liệu tham khảo
Adam, R., Russing, D., Adams, O., et al. (2005). Role of human brain microvascular endothelial cells during central nervous system infection. Significance of indoleamine 2,3-dioxygenase in antimicrobial defence and immunoregulation. Thrombosis and Haemostasis, 94, 341–346.
Brandacher, G., Winkler, C., Aigner, F., et al. (2006). Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients. Obesity Surgery, 16, 541–548.
Brandacher, G., Hoeller, E., Fuchs, D., & Weiss, H. G. (2007). Chronic immune activation underlies morbid obesity: Is IDO a key player? Current Drug Metabolism, 8, 289–295.
Floegel, A., Stefan, N., Yu, Z., et al. (2013). Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes, 62, 639–648.
Freeman, D. J., Norrie, J., Caslake, M. J., et al. (2002). C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 51, 1596–1600.
Fukushima, M., Suzuki, H., & Seino, Y. (2004a). Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Research and Clinical Practice, 66, S37–S43.
Fukushima, M., Usami, M., Ikeda, M., et al. (2004b). Insulin secretion and insulin sensitivity at different stages of glucose tolerance: A cross-sectional study of Japanese type 2 diabetes. Metabolism, 53, 831–835.
Gall, W. E., Beebe, K., Lawton, K. A., et al. (2010). Alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE, 5, e10883.
Guillemin, G. J., Kerr, S. J., Smythe, G. A., et al. (2001). Kynurenine pathway metabolism in human astrocytes: A paradox for neuronal protection. Journal of Neurochemistry, 78, 842–853.
Haffner, S. M., Stern, M. P., Hazuda, H. P., Mitchell, B. D., & Patterson, J. K. (1988). Increased insulin concentrations in nondiabetic offspring of diabetic parents. The New England Journal of Medicine, 319, 1297–1301.
Haffner, S. M., D’Agostino, R., Saad, M. F., et al. (1996). Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes, 45, 742–748.
International Diabetes Federation. (2013). IDF Diabetes Atlas (6th ed.). Brussels: International Diabetes Federation.
Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., & Natori, T. (1992). Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes, 41, 1422–1428.
Kuhara, T. (2001). Diagnosis of inborn errors of metabolism using filter paper urine, urease treatment, isotope dilution and gas chromatography-mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications, 758, 3–25.
Mangge, H., Summers, K. L., Meinitzer, A., et al. (2014). Obesity-related dysregulation of the tryptophan-kynurenine metabolism: Role of age and parameters of the metabolic syndrome. Obesity (Silver Spring), 22, 195–201.
Masuyama, T., Komeda, K., Hara, A., et al. (2004). Chronological characterization of diabetes development in male spontaneously diabetic Torii rats. Biochemical and Biophysical Research Communications, 314, 870–877.
Mitsui, R., Fukushima, M., Nishi, Y., et al. (2006). Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men. Metabolism, 55, 53–58.
Montilla, P. L., Vargas, J. F., Túnez, I. F., et al. (1998). Oxidative stress in diabetic rats induced by streptozotocin: Protective effects of melatonin. Journal of Pineal Research, 25, 94–100.
Newgard, C. B., An, J., Bain, J. R., et al. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism, 9, 311–326.
Nishiumi, S., Kobayashi, T., Ikeda, A., et al. (2012). A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS ONE, 7, e40459.
Oxenkrug, G. F. (2010). Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism. Annals of the New York Academy of Sciences, 1199, 1–14.
Rhee, E. P., Cheng, S., Larson, M. G., et al. (2011). Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. Journal of Clinical Investigation, 121, 1402–1411.
Sailaja Devi, M. M., Suresh, Y., & Das, U. N. (2000). Preservation of the antioxidant status in chemically-induced diabetes mellitus by melatonin. Journal of Pineal Research, 29, 108–115.
Sasase, T., Ohta, T., Masuyama, T., Yokoi, N., Kakehashi, A., & Shinohara, M. (2013). The spontaneously diabetic torii rat: An animal model of nonobese type 2 diabetes with severe diabetic complications. Journal of Diabetes Research, 2013, 976209.
Schrocksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D. (2006). Monitoring tryptophan metabolism in chronic immune activation. Clinica Chimica Acta, 364, 82–90.
Shah, S. H., Crosslin, D. R., Haynes, C. S., et al. (2012). Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss. Diabetologia, 55, 321–330.
Shinohara, M., Masuyama, T., Shoda, T., et al. (2000). A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. International Journal of Experimental Diabetes Research, 1, 89–100.
Thorand, B., Kolb, H., Baumert, J., et al. (2005). Elevated levels of interleukin-18 predict the development of type 2 diabetes: Results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes, 54, 2932–2938.
Tormo, M. A., Romero de Tejada, A., Morales, I., et al. (2004). Orally administered tryptophan and experimental type 2 diabetes. Molecular and Cellular Biochemistry, 261, 57–61.
Tsugawa, H., Bamba, T., Shinohara, M., Nishiumi, S., Yoshida, M., & Fukusaki, E. (2011). Practical non-targeted gas chromatography/mass spectrometry-based metabolomics platform for metabolic phenotype analysis. Journal of Bioscience and Bioengineering, 112, 292–298.
Wang, T. J., Larson, M. G., Vasan, R. S., et al. (2011). Metabolite profiles and the risk of developing diabetes. Nature Medicine, 17, 448–453.
Wang, T. J., Ngo, D., Psychogios, N., et al. (2013). 2-Aminoadipic acid is a biomarker for diabetes risk. Journal of Clinical Investigation, 123, 4309–4317.
Wang-Sattler, R., Yu, Z., Herder, C., et al. (2012). Novel biomarkers for pre-diabetes identified by metabolomics. Molecular Systems Biology, 8, 615.
World Health Organization. (1999). Definition, diagnosis, and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization [publ. no. WHO/NCD/NCS/99.2].